PT Kalbe Farma Tbk.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a PTKFY research report →
Companywww.kalbe.co.id
PT Kalbe Farma Tbk. , together with its subsidiaries, develops, manufactures, and trades in pharmaceutical products in Indonesia. The company operates through four divisions: Prescription Pharmaceuticals, Consumer Health, Nutritionals, and Distribution and Logistic.
- CEO
- Bernadette Ruth Irawati Setiady
- IPO
- 2012
- Employees
- 12,841
- HQ
- Jakarta, ID
Price Chart
Valuation
- Market Cap
- $10.64M
- P/E
- 10.38
- P/S
- 1.04
- P/B
- 1.55
- EV/EBITDA
- 6.35
- Div Yield
- 4.34%
Profitability
- Gross Margin
- 38.67%
- Op Margin
- 12.30%
- Net Margin
- 10.00%
- ROE
- 15.56%
- ROIC
- 13.15%
Growth & Income
- Revenue
- $35.32T · 8.27%
- Net Income
- $3.66T · 13.10%
- EPS
- $16176.00 · 15.28%
- Op Income
- $4.55T
- FCF YoY
- -30.38%
Performance & Tape
- 52W High
- $21.16
- 52W Low
- $9.39
- 50D MA
- $11.11
- 200D MA
- $13.54
- Beta
- 0.01
- Avg Volume
- 114
Get TickerSpark's AI analysis on PTKFY
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our PTKFY Coverage
We haven't published any research on PTKFY yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate PTKFY Report →